Valeant¬Õ§Q³Ó¹w´Á ªÑ»ù´¿¤É¹O12%
¡i©ú³ø±M°T¡j¥[°ê»sÃĶ°¹ÎValeant Pharmaceuticals International Inc.(¥N¸¹VRX)©P¤G¤½¥¬³Ó¥«³õ¹w´Áªº¦¸©u¬Õ§Q¡A¨Ãªí¥Ü±N¤ñ¹w´Á¦ÀvÁÙ¹O50»õ¬ü¤¸¶Å¶µ¡A¨ë¿E¨äªÑ»ù¤@«×¼u¤É¹O12%¡C
¦Û2016¦~4¤ë¥X¥ôValeant¦æ¬FÁ`µô¥H¨Ó¡A©¬´¶(Joseph Papa)·¥¤O««Ø¤½¥q·~°È¡A®¾¦^§ë¸êªÌªº«H¤ß¡A¦b¥L¤W¥ô«e¡AValeant¨ü¨ìºÊºÞ¾÷Ãö¤Î¬ü°ê¬F©²½Õ¬d¨ä·|p±b¥Ø¤Î©ï»ù¦æ¬°¡C
©¬´¶¨ä¤¤¤@¶µ«¤j¬D¾Ô¬O«d´î¤½¥qÃe¤j¶Å¶µ¡C¦]¬°«e¦æ¬FÁ`µô¥Öº¸»¹(Mike Pearson)³z¹L³s¦ê¦¬ÁÊ«æ³tÂX¤j·~°È¡A±a¨Óªñ300»õ¬ü¤¸¶Å°È¡CValeant©P¤Gªí¥Ü¡AÄ~Äò¿n·¥´î¶Å¡A¨Ã¸Ñ¨M¦³Ãö¶D³^¡A¨ÃºÙ¦¹L¹w´Áªº©ú¦~2¤ë«d´î50»õ¬ü¤¸¶Å¶µ¡CºI¦Ü6¤ë30¤é¡AValeantªºªø´Á¶Å¶µ¬ù¹F285»õ¬ü¤¸¡C
¤W¤ë¡AValeant±q¥X°âªvÀùÃĪ«¤À¤äDendreon Pharmaceuticals©Ò±o¡AÀvÁÙ8.11»õ¬ü¤¸¶Å¶µ¡AÁÙ¦P·N¥X°âºX¤UObagi Medical Products¡A®M²{1.9»õ¬ü¤¸¡C6¤ë®É¡AValeant¦P·N¥H9.3»õ¬ü¤¸¥X°âiNova Pharmaceuticals¡C
Á`³¡¦ì©ó»í¬ÙLavalªºiNova Pharmaceuticals²{®É¹w´ú¡A2017¦~¥þ¦~ªº¦¬¤J¤¶¥G87»õ¦Ü89»õ¬ü¤¸¡A¦ý¤§«e¹w´ú±N¤¶¥G89»õ¦Ü91»õ¬ü¤¸¡C¤£¹L¡A¶°¹Îºû«ù¨ä2017¦~¥þ¦~¸g½Õ¾ã«á¥¼p§Q®§¡Bµ|¶µ¡B§é»PÅu¾P«e¬Õ§Q¹w´ú¡C
Yç°£¤@¦¸¹L¶µ¥Ø¡AValeant²Ä¤G©u¤º¿ý±o¨CªÑ¬Õ§Q1.05¬ü¤¸¡A¾Ú´ö»¹¸ô³z½Õ¬d©Ò±o¡A¤ÀªRû¥§¡¹w´ú¬°94¬ü¥P¡C¯à°÷¨ú±o¶W¶V¤ÀªRûªº¸g½Õ¾ã«á¬Õ§Q¡A¥Dn±o§U©óªvÀø¹L±Ó©Ê¸zºî¦X¯fÃĪ«Xifaxanªº±j«l¾P°â¡CValeant¦¸©u«×¦¬¤J¤jP²Å¦X¤ÀªRû¹w´ú¡C
¬ü°ê¹ª«¤ÎÃĪ«ºÞ²z§½©P¤@©ó²¤¦h©ó1¦~¤º²Ä¤G¦¸©Úµ´§åãValeant²´ÃÄ¡C³o¥O¤HÃöª`¨ìValeantÄݤU³Õ¤hÛ¦b¬ü°ê¦òù¨½¹FTampaªº¥Í²£³]¬I¡C
Valeant©P¤@¦b¦hÛ¦hÃÒ¨é¥æ©ö©Ò¥H21.45¤¸°ª¶}¡A´¿¤É¦Ü21.52¤¸¡A¤ñ¤W©P¤¦¬¥«»ù°ª¥X12.38%¡A³Ì«á¦¬³ø19.74¤¸¡A¤W¤É0.59¤¸¡A©Î3.08%¡C